JMDSJournal of Medicines Development Sciences2382-63632382-6371Bio-Byword Scientific Publishing Pty. Ltd.10.26689/JMDS.v11i3.15984ArticleDiscussion on the Practice of Chronic Disease Medication and Exercise Guidance in Community Pharmaceutical Serviceshttps://artdesignp.com/journal/JMDS/11/3/10.26689/JMDS.v11i3.15984SunHui20261132026-09-16Objective: To explore the practical effect of applying chronic disease medication and exercise guidance in community pharmaceutical services. Methods: 82 patients with chronic diseases were selected for data analysis from July 2024 to June 2025 at the Central Health Center of Dongshuanggou Town, Hongze District, Huai’an City, Jiangsu Province. They were divided into groups using the random number table method, with 41 patients in each group. The experimental group received conventional community pharmaceutical services plus chronic disease medication and exercise guidance, and the control group received conventional community pharmaceutical services. The data differences between the groups were compared. Results: Compared with the control group, the test group had significantly lower blood pressure and blood sugar after intervention, significantly higher medication compliance, significantly higher post-intervention quality of life scores, and significantly lower incidence of adverse reactions P < 0.05. Comparing the blood pressure, blood sugar, and quality of life scores between the two groups before intervention, P > 0.05. Conclusion: The practical effect of applying chronic disease medication and exercise guidance in community pharmaceutical services is ideal.Community pharmaceutical services, Chronic disease medication, Exercise guidance, Practical effects

[1] Li Z, 2023, Evaluation of the Effect of Intensive Pharmaceutical Services on Improving Medication Compliance and Blood Pressure Levels of Community-Based Hypertensive Patients. Primary Medicine Forum, 27(26): 120–122. [2] Liu X, Tang X, 2025, Application Effect of Home Pharmacy Service Model Based on Family Doctor Contract Service Among Community Patients with Chronic Diseases. Chinese Community Physician, 41(32): 13–15. [3] Zhou M, Zhang L, Lian Y, et al., 2025, The Impact of Pharmaceutical Services Under the Medical Collaboration Model on Disease Control and Health Behaviors of Elderly Patients with Chronic Diseases in the Community. Chinese Hospital Statistics, 32(5): 331–335. [4] Yang Y, Li C, Qin W, et al., 2023, Current Status and Development Suggestions of Community Pharmaceutical Services in China. Pharmaceutical Research, 42(12): 1042–1046. [5] Yao W, Zhong X, Yao Y, 2025, Analysis of Factors Related to Blood Sugar Control and Research on the Effect of Pharmaceutical Service Intervention in Community Patients with Type 2 Diabetes. Chinese Medical Science, 15(16): 154–158. [6] Liu X, Yang S, Chen X, 2025, Construction and Implementation of Home Pharmaceutical Service System for Community Chronic Diseases. Clinical Rational Drug Use, 18(5): 136–139. [7] Xu X, Cao W, Wang L, et al., 2025, Practice in Establishing a New Community Pharmaceutical Service Model Under the Medical Alliance. Chinese Pharmaceutical Industry, 34(2): 13–18. [8] Yuan Q, Pu C, Li B, et al., 2024, Current Status and Solutions of Community Pharmacy Services in China. Chinese Pharmacoeconomics, 19(7): 103–107. [9] Zhang B, 2024, Analysis of the Clinical Effect of Community Pharmaceutical Services in the Health Management of Patients with Type 2 Diabetes. Chinese Community Physician, 40(19): 10–12. [10] Zhang Y, Jiang Y, 2024, Construction and Application of “School-Enterprise-Community” Linkage Community Pharmacy Service Model Based on WeChat Applet. Chinese Pharmacy, 35(1): 107–111. [11] Zhou X, Ye Y, 2023, Observation on the Application Effect of Pharmaceutical Services in the Disease Management of Elderly Patients with Chronic Diseases in the Community Under the Family Doctor Contracting System. Chinese Practical Medicine, 18(18): 159–163.